Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Buy Greif, Inc. (GEF)?

Page 1 of 2

As we already know from media reports and hedge fund investor letters, many hedge funds lost money in the third quarter, blaming macroeconomic conditions and unpredictable events that hit several sectors, with healthcare among them. Nevertheless, most investors decided to stick to their bullish theses and their long-term focus allows us to profit from the recent declines. In particular, let’s take a look at what hedge funds think about Greif, Inc. (NYSE:GEF) in this article.

Greif, Inc. (NYSE:GEF) investors should be aware of an increase in hedge fund interest lately. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article, we will examine companies such as ABM Industries, Inc. (NYSE:ABM), China Lodging Group, Ltd (ADR) (NASDAQ:HTHT), and M/A-COM Technology Solutions Holdings (NASDAQ:MTSI) to gather more data points.

Follow Greif Inc
Trade (GEF,GEF.B) Now!

In the 21st century investor’s toolkit, there are tons of signals market participants can use to value stocks. A couple of the most under-the-radar signals are hedge fund and insider trading moves. Our researchers have shown that, historically, those who follow the top picks of the top fund managers can outpace their index-focused peers by a significant margin (see the details here).

Now, we’re going to analyze the fresh action surrounding Greif, Inc. (NYSE:GEF).

How are hedge funds trading Greif, Inc. (NYSE:GEF)?

At the end of the third quarter, a total of 21 of the hedge funds tracked by Insider Monkey were long this stock, an increase of 50% from the previous quarter. With the smart money’s capital changing hands, there exists a few notable hedge fund managers who were increasing their stakes significantly (or already accumulated large positions).

According to Insider Monkey’s hedge fund database, Paul J. Isaac’s Arbiter Partners Capital Management has the number one position in Greif, Inc. (NYSE:GEF), worth close to $35.2 million, accounting for 3.4% of its total 13F portfolio. The second most bullish fund manager is Chuck Royce of Royce & Associates, with a $32.6 million position; 0.2% of its 13F portfolio is allocated to the stock. Other members of the smart money that hold long positions contain Mario Gabelli’s GAMCO Investors, Paul Marshall and Ian Wace’s Marshall Wace LLP, and Israel Englander’s Millennium Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!